Hideo Wada Selected Research

Hideo Wada Research Topics

Disease

86	Disseminated Intravascular Coagulation 01/2024 - 03/2002
56	Thrombosis (Thrombus) 01/2024 - 03/2002
26	Neoplasms (Cancer) 03/2024 - 04/2002
25	Infections 01/2023 - 06/2002
24	Sepsis (Septicemia) 11/2023 - 06/2002
23	Hemorrhage 03/2024 - 08/2002
19	Thrombotic Thrombocytopenic Purpura 11/2023 - 05/2002
18	Venous Thromboembolism 03/2024 - 01/2005
17	Thrombocytopenia (Thrombopenia) 11/2023 - 01/2008
17	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021 - 08/2004
14	Thrombotic Microangiopathies 04/2023 - 04/2005
13	Thrombophilia 11/2023 - 04/2003
11	Communicable Diseases (Infectious Diseases) 02/2021 - 04/2003
9	Hemophilia A (Haemophilia) 09/2023 - 11/2017
9	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2021 - 08/2004
8	Hemolytic-Uremic Syndrome 06/2019 - 05/2002
8	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2017 - 10/2003
7	Atypical Hemolytic Uremic Syndrome 04/2023 - 05/2012
7	Wounds and Injuries (Trauma) 04/2017 - 08/2002
7	Pulmonary Embolism 10/2011 - 08/2004
5	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 08/2011
5	COVID-19 05/2023 - 08/2021
5	Critical Illness (Critically Ill) 03/2023 - 01/2005
5	Connective Tissue Diseases (Connective Tissue Disease) 01/2019 - 12/2015
4	Cerebral Infarction 03/2024 - 07/2021
4	Hemolytic Anemia 11/2023 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 04/2002
4	Leukemia 01/2021 - 08/2002
4	Lymphoma (Lymphomas) 01/2006 - 01/2003
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 11/2008
3	Liver Diseases (Liver Disease) 01/2024 - 07/2005
3	Inflammation (Inflammations) 02/2023 - 11/2005
3	Colonic Neoplasms (Colon Cancer) 06/2022 - 01/2014
3	Fibrosis (Cirrhosis) 06/2019 - 12/2004
3	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2002
3	Heart Failure 01/2016 - 12/2004
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2006 - 07/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2010
2	Bacterial Infections (Bacterial Infection) 04/2023 - 06/2009
2	Myocardial Infarction 03/2023 - 07/2021
2	Thromboembolism 03/2023 - 06/2010
2	Shock 02/2023 - 08/2010

Drug/Important Bio-Agent (IBA)

87	Dacarbazine (DIC)FDA LinkGeneric 01/2024 - 03/2002
29	AntithrombinsIBA 11/2023 - 07/2002
28	Hemostatics (Antihemorrhagics)IBA 01/2024 - 08/2002
27	fibrin fragment D (D-dimer)IBA 03/2024 - 01/2003
26	FibrinIBA 04/2023 - 03/2002
22	Fibrinogen (Factor I)FDA Link 03/2023 - 03/2002
18	thiamine triphosphorate (TTP)IBA 11/2023 - 05/2002
15	ThrombomodulinIBA 01/2024 - 08/2002
13	AnticoagulantsIBA 01/2024 - 01/2005
12	Thromboplastin (Tissue Factor)IBA 01/2024 - 04/2002
12	formycin diphosphate (FDP)IBA 03/2023 - 03/2002
11	Thrombin FDA Link 09/2023 - 07/2002
9	C-Type Lectins (C-Type Lectin)IBA 01/2024 - 06/2019
9	von Willebrand FactorIBA 02/2023 - 01/2005
9	Inosine Triphosphate (ITP)IBA 12/2021 - 08/2004
9	Protein SIBA 10/2018 - 10/2003
8	Protein CIBA 10/2018 - 01/2003
7	Fibrin Fibrinogen Degradation ProductsIBA 01/2022 - 04/2003
7	Messenger RNA (mRNA)IBA 01/2006 - 04/2003
6	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2020
6	Metalloproteases (Metalloproteinases)IBA 11/2014 - 10/2004
6	ThrombospondinsIBA 11/2014 - 10/2004
6	DisintegrinsIBA 11/2014 - 10/2004
5	Complement System Proteins (Complement)IBA 04/2023 - 11/2014
5	Proteins (Proteins, Gene)FDA Link 03/2017 - 10/2004
5	Fondaparinux (Arixtra)FDA Link 05/2016 - 10/2011
5	AntigensIBA 09/2015 - 07/2004
4	emicizumabIBA 09/2023 - 11/2017
4	Factor VIII (Coagulation Factor VIII)IBA 09/2023 - 01/2011
4	eculizumab FDA Link 04/2023 - 04/2016
4	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 04/2005
4	C-Reactive ProteinIBA 03/2020 - 07/2005
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 08/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 06/2009
4	antithrombin III-protease complexIBA 01/2013 - 08/2002
3	Blood Coagulation Factors (Coagulation Factor)IBA 11/2023 - 01/2020
3	BilirubinIBA 05/2023 - 11/2018
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020 - 08/2004
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 09/2017
3	AntibodiesIBA 10/2018 - 08/2004
3	platelet membrane glycoprotein VIIBA 04/2017 - 03/2014
3	Hemoglobins (Hemoglobin)IBA 01/2017 - 02/2012
3	Antiphospholipid AntibodiesIBA 01/2016 - 01/2013
3	Heparin (Liquaemin)FDA LinkGeneric 09/2014 - 05/2009
3	CytokinesIBA 01/2013 - 01/2005
3	fibrinmonomerIBA 09/2012 - 01/2003
3	LipidsIBA 01/2005 - 07/2003
3	Thomsen-Friedenreich antigenIBA 01/2005 - 07/2004

Therapy/Procedure

19	Therapeutics 11/2023 - 04/2008
10	Liver Transplantation 05/2023 - 08/2005
8	Orthopedic Procedures 01/2021 - 02/2012
5	Hepatectomy 01/2021 - 11/2008
4	Renal Dialysis (Hemodialysis) 01/2022 - 01/2003
4	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 10/2011
4	Drug Therapy (Chemotherapy) 05/2020 - 07/2005
4	Splenectomy 03/2018 - 11/2008
3	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2021 - 10/2011
3	Plasma Exchange 02/2013 - 05/2002